CHANGE OF NON-SPECIFIC FACTORS OF IMMUNITY UNDER INFLUENCE OF INTERFERON INDUCTOR (CYCLOFERON) IN BRONCHIAL ASTHMA IN CHILDREN

  • V. H. Chernuskyi V.N. Karazin Kharkiv National University, Kharkiv, Ukraine https://orcid.org/0000-0001-5657-9486
  • M. M. Popov V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
  • H. V. Letiaho V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
  • O. L. Hovalenkova V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
  • V. L. Kashina-Yarmak V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
  • T. V. Yevdokymova V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
  • O. A. Gurova V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
Keywords: bronchial asthma, children, phagocytic activity, interferon inducers

Abstract

The aim of the work was to evaluate the effect of immunomodulation therapy on factors of nonspecific immunity in children with bronchial asthma (BA) by including interferon (cycloferon) in a standard therapy. 120 children with BA aged from 5 to 14 were examined. The main group (n = 60) included children who, in addition to basic therapy, received an interferon inducer (cycloferon) according to the generally accepted scheme. In comparison group were children who received only basic therapy (n = 60), depending on the severity of the disease. In control group were 25 healthy children. The level of serum interferon, virus-induced interferon production (VII), mitogen-stimulated production of interferon (MSI), phagocytic activity of neutrophils, as well as spontaneous and induced activity were determined. The arithmetic mean (M) and the absolute value error (m) were statistically calculated. The reliability of the differences was determined by the t-test of the Student (p < 0,05). The analysis of the indices of interferon status and phagocytic activity, depending on the type of therapeutic tactics, showed that as a result of the inclusion of cycloferon in the baseline, there was a significant increase in the levels of VII (p < 0,05) and MSI (p < 0,05 ), spontaneous and induced neutrophil activity. It was noted that this positive effect was more noticeable in moderate and severe BA (p < 0,05). Activation of factors of nonspecific protection contributed to a decrease in the frequency of exacerbations of BA in children, as well as a longer-term clinical remission in this contingent of children.

Downloads

Download data is not yet available.

Author Biographies

V. H. Chernuskyi, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

Svobody sq., 6, Kharkiv, 61022, Ukraine

 
M. M. Popov, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

Svobody sq., 6, Kharkiv, 61022, Ukraine

 
H. V. Letiaho, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

Svobody sq., 6, Kharkiv, 61022, Ukraine

 
O. L. Hovalenkova, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

площа Свободи, 6, Харків, 61022, Україна

 
V. L. Kashina-Yarmak, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

Svobody sq., 6, Kharkiv, 61022, Ukraine

 
T. V. Yevdokymova, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

Svobody sq., 6, Kharkiv, 61022, Ukraine

 
O. A. Gurova, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine

Svobody sq., 6, Kharkiv, 61022, Ukraine

 

References

Balabolkin I. I. Bronkhial'naya astma u detey / I. I. Balabolkin, V. A. Bulgakova. – Moskva : MIA, 2015. – 144 s.

Geppe N. A. Aktual'nost' problemy bronkhial'noy astmy u detey / N. A. Geppe // Pediatriya. – 2012. –T. 91, No 3. – S. 76–82.

Kaydashev I. P. T-kletochnaya regulyatsiya pri atopicheskikh zabolevaniyakh / I. P. Kaydashev // Klinicheskaya immunologiya. Allergologiya. Infektologiya. – 2011. –No 9. – S. 18–21.

Okhotnikova Ye. N. Patogeneticheskiye osobennosti bronkhoobstruktivnogo sindroma u detey i sovremennyye vozmozhnosti neotlozhnoy terapii / Ye. N. Okhotnikova // Astma i allergiya. – 2013. –No 2. – S. 52–61.

Okhotnikova Ye. N. Bronkhial'naya astma u detey rannego vozrasta: osobennosti lecheniya / Ye. N. Okhotnikova // Klinicheskaya immunologiya, allergologiya, infektologiya. – 2014. –No 4. – S. 5–11.

Chernysheva O. Ye. Sovremennyye predstavleniya o patogeneze bronkhial'noy astme u detey / O. Ye. Chernysheva // Zdorov'ye rebenka. – 2014. –No 5. – S. 84–90.

Papadopoulos N. G. International consensus on (ICON) pediatric asthma / N. G. Papadopoulos [et al.] // Allergy. – 2012. – Vol. 67. – P. 976–997.

Zaytseva O. V. Virusindutsirovannaya bronkhial'naya astma u detey: znacheniye sistemy interferona / O. V. Zaytseva, E. E. Lokshina, S. V. Zatseva // Pediatriya. Zhurnal im. G.N. Speranskogo. – 2017. –No 2. – S. 99–105.

Bergauer A. IFN-α/IFN-λ responses to respiratory viruses in paediatric asthma / A. Bergauer, N. Sopel, B. Krob // Eur Respir J. – 2017. –No 49. – P. 96–110.

Koch S. Role of Interferon-γ in Allergic Asthma / S. Koch, S. Finotto // J. Innate Immun. – 2015. –No 7. –P. 224–230.

Lambrecht N. B. The immunology of asthma / N. B. Lambrecht, H. Hammad // Nature Immunology. –2015. –No 16. – P. 45–56.

Khaitov M. R. Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells / M. R. Khaitov, V. Laza-Stanca, M. R. Edwards // Allergy. –2009. – Vol. 64, issue 3. – P. 375–386.

Anisimova N. YU. Fenotip i fagotsitarnaya aktivnost' neytrofilov krovi bol'nykh bronkhial'noy astmoy v periode obostreniya / N. YU. Anisimova // Immunologiya. – 2012. –No 6. – S. 318–322.

Macharadze D. SH. Virusy i astma: bol'she voprosov, chem otvetov / D. SH. Macharadze // Lechashchiy vrach. – 2009. –No 10. – S. 69–76.

Published
2017-09-11
How to Cite
Chernuskyi, V. H., Popov, M. M., Letiaho, H. V., Hovalenkova, O. L., Kashina-Yarmak, V. L., Yevdokymova, T. V., & Gurova, O. A. (2017). CHANGE OF NON-SPECIFIC FACTORS OF IMMUNITY UNDER INFLUENCE OF INTERFERON INDUCTOR (CYCLOFERON) IN BRONCHIAL ASTHMA IN CHILDREN. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine&quot;, (33), 6-10. Retrieved from https://periodicals.karazin.ua/medicine/article/view/9042
Section
Clinical research